v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash $ 3,784 $ 1,538
Accounts receivable 16 15
Prepaid expenses, deposits, and other current assets 1,058 1,004
Total current assets 4,858 2,557
Fixed assets, net 73 77
Operating lease right-of-use assets 1,738 2,002
Equity method investment - at fair value 33,494 34,120
Other assets 51 56
Total assets 40,214 38,812
Current liabilities:    
Accounts payable 1,056 678
Accrued expenses and other current liabilities 2,462 2,486
Operating lease liabilities, current portion 570 573
Senior Secured Convertible Notes - at fair value 0 11,100
Total current liabilities 4,088 14,837
Senior Secured Convertible Notes - at fair value 15,100 0
Operating lease liabilities, less current portion 1,398 1,675
Total liabilities 20,907 16,512
Commitments and contingencies (Note 7)
Stockholders’ Equity (Deficit):    
Common stock, $0.001 par value. Authorized, 25,000,000 shares (Note 12); 6,269,418 and 927,934 shares outstanding as of June 30, 2026 and December 31, 2025, respectively 6 1
Additional paid-in capital 295,697 268,019
Accumulated deficit (264,505) (258,731)
Total PAVmed Stockholders’ Equity (Deficit) 35,048 33,967
Noncontrolling interests (15,741) (11,667)
Total Stockholders’ Equity (Deficit) 19,307 22,300
Total liabilities and stockholders’ equity 40,214 38,812
Series B Preferred Stock [Member]    
Stockholders’ Equity (Deficit):    
Preferred stock 3,850 3,665
Series C Preferred Stock [Member]    
Stockholders’ Equity (Deficit):    
Preferred stock 0 21,013
Rights Liability [Member]    
Current liabilities:    
Rights liability $ 321 $ 0